All raw mass spectrometry files and associated information are available on Chorus under Project ID 999 and Experiment ID 3166. Data can be found at <https://chorusproject.org/pages/dashboard.html#/search/999/projects/999/experiments/3166/files>. Strain details are listed in the information tab.

Introduction {#sec001}
============

Lignocellulosic biomass offers a sustainable source for bioenergy. The use of leftover agriculture byproducts and plants grown on marginal lands for biofuel production reduces waste and removes dependency on food-based cropping systems. Notably, there are two major bottlenecks for sustainable biofuel production from lignocellulosic material. First, many microbes, including industrially relevant *Saccharomyces cerevisiae*, cannot innately ferment pentose sugars like xylose, which comprise a significant fraction of the sugars released from deconstructed biomass \[[@pone.0212389.ref001]\]. Second, the harsh chemical treatment of plant biomass required to release lignocellulosic sugars produces a variety of toxins and stresses that inhibit microbial growth and fermentation \[[@pone.0212389.ref002],[@pone.0212389.ref003]\]. A goal for the biofuel industry is to engineer stress-tolerant microbes to convert all available sugars to the desired products by routing cellular resources toward product formation and away from cell growth and other unnecessary physiological responses \[[@pone.0212389.ref004]\].

Several labs have evolved or engineered yeast for anaerobic xylose usage, introducing either xylose isomerase \[[@pone.0212389.ref005]--[@pone.0212389.ref007]\] or xylose reductase (XR) with xylitol dehydrogenase (XDH) \[[@pone.0212389.ref008]--[@pone.0212389.ref013]\], and over-expressing xylulokinase for increased flux \[[@pone.0212389.ref014]--[@pone.0212389.ref017]\]. However, most strains do not use xylose unless further evolved through laboratory selection \[[@pone.0212389.ref007],[@pone.0212389.ref018]--[@pone.0212389.ref021]\]. In some cases, the genetic basis for evolved improvements in anaerobic utilization are known from sequencing of evolved lines. We previously engineered a stress-tolerant strain with XR and XDH (strain Y22-3) and evolved it for aerobic xylose respiration, producing strain Y127. To enable anaerobic xylose fermentation, Y127 was propagated anaerobically on xylose, generating strain Y128 \[[@pone.0212389.ref021]\]. Aerobic xylose respiration in the Y127 strain was enabled by null mutations of the Fe-S cluster protein *ISU1* and the osmotic stress response MAP kinase *HOG1*. Maximal anaerobic fermentation in the evolved Y128 strain was facilitated by these mutations plus additional null mutations of the negative regulator of RAS/PKA signaling, *IRA2*, and *GRE3*, an aldose reductase that siphons xylose to xylitol \[[@pone.0212389.ref022]\]. A subsequent study independently generated an anaerobic-xylose fermenting strain, confirmed the requirement of the *ISU1* deletion, and further found deletion of the upstream HOG pathway regulator *SSK2* improved xylose fermentation \[[@pone.0212389.ref023]\]. Thus, mutations in these pathways play a generalizable role in anaerobic xylose fermentation across labs and strains.

While mutations that promote xylose utilization are known, the specific roles for each mutation and how the RAS/PKA and HOG pathways intersect to enable anaerobic xylose utilization remain unclear. RAS signaling promotes growth on preferred nutrients like glucose, in part by activating adenylate cyclase to produce cAMP, which binds to the PKA negative regulatory subunit Bcy1 to enable PKA activity \[[@pone.0212389.ref024]\]. Ira1/2 are the GTPase activating proteins (GAPs) that inhibit Ras1/2 by converting GTP (RAS-active state) to GDP (RAS-inactive state). On the other hand, Hog1 is best characterized as an osmotic stress response MAP kinase and leads to the upregulation of stress-responsive transcription factors and other enzymes and defense systems \[[@pone.0212389.ref025]\]. How Hog1 contributes to xylose fermentation is unknown, although the kinase was recently shown to play a role in the response to glucose levels \[[@pone.0212389.ref026]--[@pone.0212389.ref030]\]. PKA and Hog1 have opposing roles on the stress response: PKA activates transcription factors required for growth-promoting genes and directly suppresses stress-activated transcription factors like Msn2/Msn4, while Hog1 activity induces stress-defense regulators and contributes to the repression of growth-promoting genes \[[@pone.0212389.ref031]\].

Increased stress sensitivity is a major limitation for industrial use of evolved strains with RAS/PKA and HOG mutations and a barrier to sustainable lignocellulosic bioenergy production. Chemical pretreatment of plant biomass is required to release fermentable sugars into the resulting "hydrolysate." This treatment produces a variety of toxins and stressors that limit microorganisms' ability to ferment, particularly impacting fermentation and growth during xylose consumption \[[@pone.0212389.ref002],[@pone.0212389.ref032],[@pone.0212389.ref033]\]. One group of toxins are lignocellulosic hydrolysate inhibitors (or lignotoxins), which are released from breakdown of hemicellulose and cellulose and include furans, phenolics, and aliphatic acids. Lignotoxins disrupt central carbon metabolism pathways by generating reactive oxygen species and depleting the cells of ATP, NADH, and NADPH, in part through increased activity of ATP-dependent efflux pumps and detoxification \[[@pone.0212389.ref034]--[@pone.0212389.ref036]\], ultimately decreasing available resources for growth and metabolism. Therefore, strains must be tolerant to the toxins present in hydrolysate for efficient fermentation of lignocellulosic material, but the mutations required for efficient anaerobic xylose fermentation produce stress-susceptible strains. Upregulated PKA activity suppresses stress-defense pathways \[[@pone.0212389.ref037]--[@pone.0212389.ref040]\], while *HOG1* deletion decreases cells' ability to mount a stress response. This likely has a direct impact on existing strains, limiting their industrial use. One possible solution is increasing stress tolerance in these strains will enable better anaerobic xylose fermentation in industrially relevant hydrolysates. Other groups have found varying levels of success improving toxin tolerance \[[@pone.0212389.ref003]\] through overexpression of stress response transcription factors \[[@pone.0212389.ref041],[@pone.0212389.ref042]\], mitochondrial NADH-cytochrome b5 reductase \[[@pone.0212389.ref042]\], an oxidative stress protein kinase \[[@pone.0212389.ref043]\], and furaldehyde reductases \[[@pone.0212389.ref044]\], as well as through mating, gene shuffling, and evolution \[[@pone.0212389.ref045]--[@pone.0212389.ref048]\].

We recently discovered an alternate strategy of enabling anaerobic xylose fermentation, one that we predicted may augment stress tolerance. Perturbing sequence of the PKA regulatory subunit Bcy1 through simple protein fusion (with either a 260 amino acid auxin-inducible degron (AiD) tag without degradation capabilities or merely GFP) promotes anaerobic xylose fermentation equal to strain Y128 without the need for *HOG1* or *IRA2* deletion \[[@pone.0212389.ref049]\]. Since this strain retains functional Hog1 and grows well on glucose, we predicted the strain may have improved stress tolerance, which could enhance growth and xylose fermentation in 9% AFEX-pretreated corn stover hydrolysate (ACSH).

Here, we set out to dissect the contributions of regulators in the RAS/PKA and HOG pathways to anaerobic xylose fermentation, growth, and stress resistance. We demonstrate that while upregulating PKA is important for increased cell growth on glucose, *HOG1* deletion specifically benefits xylose utilization, in part by preventing phosphorylation of glycolytic enzymes by Hog1. Our results show perturbing Bcy1 sequence by protein fusion dramatically improved stress tolerance, as seen by increased growth in toxic 9% glucan-loading ACSH, but xylose fermentation remained blocked, suggesting physiological stress sensitivity is unlikely the cause of halted xylose consumption in concentrated hydrolysate.

Methods {#sec002}
=======

Strains and media {#sec003}
-----------------

Strains used in this study are listed in [Table 1](#pone.0212389.t001){ref-type="table"}. All strains expressed a codon-optimized cassette containing *XYLA* from *Clostridium phytofermentans*, *XYL3* from *Scheffersomyces stipitis*, and *TAL1* from *S*. *cerevisiae* \[[@pone.0212389.ref021]\]. Generation of strains Y22-3, Y128, Y184, Y184 *ira2Δ*, Y184 *hog1Δ*, Y184 *ira2Δhog1Δ*, Y184 *bcy1Δ*, and 184 Bcy1-AiD was previously described \[[@pone.0212389.ref021],[@pone.0212389.ref022],[@pone.0212389.ref049]\]. Y184 *ira2Δbcy1Δ* was made by replacing *BCY1* with *KanMX* marker in Y184 *ira2Δ*, and verified with diagnostic PCRs. *HOG1* was complemented in Y184 *ira2Δhog1Δ* on a low-copy MoBY 1.0 plasmid \[[@pone.0212389.ref050]\]. Site-directed mutagenesis was performed to express the *hog1*^*D144A*^ or *hog1*^*A844Δ*^ allele from the MoBY 1.0 plasmid, and correct mutants were verified by sequencing. Strains harboring *HOG1*, *hog1*^*D144A*^, or *hog1*^*A844Δ*^ expressing plasmids or the empty-vector control were grown in media containing G418 to maintain the plasmid.

10.1371/journal.pone.0212389.t001

###### Strains used in this study.

![](pone.0212389.t001){#pone.0212389.t001g}

  Strain ID                     Genotype                                                                                            Reference
  ----------------------------- --------------------------------------------------------------------------------------------------- ----------------------------------------
  Y22-3                         NRRL YB-210 MATa spore *HOΔ*::*ScTAL1-CpxylA-SsXYL3-loxP-KanMX-loxP*                                \[[@pone.0212389.ref021]\]
  Y128                          Y22-3 MATa, *isu1C412T*, *hog1A844del*, *gsh1G839A*, *gre3G136A*, *ira2G8782T*, *sap190A2590G*      \[[@pone.0212389.ref021]\]
  Y184                          Y22-3 MATa, *isuΔ*::*loxP-Hyg-loxP*, *gre3Δ*::*MR*                                                  \[[@pone.0212389.ref049]\]
  Y184 *ira2Δ*                  Y184, *ira2Δ*::*MR*                                                                                 \[[@pone.0212389.ref022]\]
  Y184 *bcy1Δ*                  Y184, *bcy1Δ*::*KanMX*                                                                              \[[@pone.0212389.ref049]\]
  Y184 *hog1Δ*                  Y184, *hog1Δ*::*KanMX*                                                                              \[[@pone.0212389.ref022]\]
  Y184 Bcy1-AiD                 Y184, BCY1-3\' AiD tag (3x Mini-Auxin Induced Degron Sequence-5x FLAG-BCY1-3\' UTR-KanMX) (G418R)   \[[@pone.0212389.ref049]\]
  Y184 *ira2Δhog1Δ*             Y184, *ira2Δ*::*MR*, *hog1Δ*::*KanMX*                                                               \[[@pone.0212389.ref022]\]
  Y184 *ira2Δbcy1Δ*             Y184, *ira2Δ*::*MR*, *bcy1Δ*::*KanMX*                                                               This study
  Y184 *ira2Δhog1Δ/HOG1*        Y184 *ira2Δhog1Δ*, *HOG1 (*CEN4 plasmid: *KanMX*, *URA3*)                                           This study, \[[@pone.0212389.ref050]\]
  Y184 *ira2Δhog1Δ/hog1D144A*   Y184 *ira2Δhog1Δ*, *hog1D144A (*CEN4 plasmid: *KanMX*, *URA3*)                                      This study, \[[@pone.0212389.ref050]\]
  Y184 *ira2Δhog1Δ/A884Δ*       Y184 *ira2Δhog1Δ*, *hog1A844del (*CEN4 plasmid: *KanMX*, *URA3*)                                    This study, \[[@pone.0212389.ref050]\]
  Y184 *ira2Δhog1Δ/*empty       Y184 *ira2Δhog1Δ*, CEN4 plasmid: *KanMX*, *URA3*                                                    This study, \[[@pone.0212389.ref050]\]
  Y184 *ira2Δ/*empty            Y184 *ira2Δ*, CEN4 plasmid: *KanMX*, *URA3*                                                         This study, \[[@pone.0212389.ref050]\]

YPDX medium was prepared as previously described \[[@pone.0212389.ref051]\] (1% yeast extract, 2% peptone, except that sugars were added at either 6% glucose and 3% xylose or 9% glucose and 4.5% xylose). Identified lignotoxins \[[@pone.0212389.ref052],[@pone.0212389.ref053]\] ([S1 Table](#pone.0212389.s005){ref-type="supplementary-material"}) were added to YPDX 6%/3% and the medium was sterilized by vacuum filtration. ACSH was prepared from *Zea mays* (Pioneer hybrid 36H56) grown in Field 570-C Arlington Research Station, University of Wisconsin and harvested in 2012, as previously described \[[@pone.0212389.ref054]\]. Pretreated corn stover was hydrolyzed to either 6% or 9% glucan loading at 50°C for 5 days, and biomass was added 4 hours after hydrolysis began in 4 batches. The hydrolysate was centrifuged (2500xg for 30 minutes) and sterile filtered (0.22 μm pore size; Millipore Stericup). Final sugar concentrations were 53 g/L glucose and 21.7 g/L xylose for 6% glucan-loading ACSH, and 80 g/L glucose and 36 g/L xylose for 9% glucan-loading ACSH. Osmolality of media was measured with a Wescor VAPRO® Vapor Pressure Osmometer 5600.

TECAN screening {#sec004}
---------------

Strains were grown to saturation in YPD 2% batch aerobically overnight, then diluted to an OD~600~ of 2 in YPD 2%. 5 μL of culture was added to 95 μL of 9% ACSH, YPDX 9%/4.5%, YPDX 6%/3%, or YPDX 6%/3% +LT in a Costar clear 96-well plate. OD at 600 nm was measured anaerobically for 48 hours in a TECAN Infinite 200 at 30°C, with measurements taken every 20 minutes (total of 144 measurement cycles) and multiple reads per well. Final OD was calculated based on the average OD reading per well per time point and using three biological replicates. Significant differences compared to Y184 were determined by performing a paired T-test at *p* \< 0.05, pairing sample by replicate date.

Batch culture fermentations {#sec005}
---------------------------

Overnight aerobic cultures grown in YPD 2% glucose were transferred to an anaerobic chamber, washed once with anaerobic medium, and inoculated into the tested media at an OD~600~ of 0.1. Fermentations occurred for 96 hours, with 1 mL aliquots removed throughout the time course for OD~600~ measurements and HPLC-RID analysis to measure glucose, xylose, and ethanol concentrations. Dry-cell weight biomass was measured by vacuum filtering cultures onto pre-weighed filters (0.45 μm pore size), microwaving on 10% power for 10 minutes, then drying in a desiccant for 24 hours before measuring. Biomass, OD, and concentrations of glucose, xylose, and ethanol were averaged from three biological replicates for each time point. ANOVA was used to determine significant differences in biomass, comparing 24h and 48h within each individual strain, at *p* \< 0.05. Rates of sugar consumption were calculated by normalizing the change in sugar concentration to the fitted rate of biomass change during exponential (glucose) or stationary (xylose) phase, and a paired T-test was used to determine significant differences compared to Y184 at *p* \< 0.05. Ethanol titer at 48h was averaged from three biological replicates.

Phosphoproteomic analysis {#sec006}
-------------------------

Quantitative proteomic and phosphoproteomic samples of Y184 *ira2Δhog1Δ* and Y184 *hog1Δ* were prepared as previously described using isobaric tandem mass tags (TMT) for phosphoproteomic analysis \[[@pone.0212389.ref049]\]. Paired samples were collected from two independent replicates grown anaerobically in YPX 3% for three generations and harvested at OD~600~ \~0.5. Proteomic samples were analyzed by nanoflow liquid chromatography tandem mass spectrometry. COMPASS \[[@pone.0212389.ref055]\] was used to search against target-decoy yeast database \[[@pone.0212389.ref056]\]. Raw data were transformed to log~2~ values, then the fold change between Y184 *ira2Δhog1Δ* and Y184 *ira2Δ* peptides was calculated. We focused on differentially abundant phosphopeptides, defined as those with a log~2~ difference of at least 1.5X in the same direction in both replicate comparisons. We used this threshold since TMT tagging is known to compress abundance differences \[[@pone.0212389.ref057]\].

Results {#sec007}
=======

Our goal was to dissect the contributions of different regulators in growth, xylose fermentation, and stress tolerance. We therefore measured fermentation and growth rates of a panel of strains grown in several concentrations of ACSH and laboratory media. To clarify the contribution of each regulator, we started with strain Y22-3, which overexpresses a codon-optimized cassette containing *XYLA* from *Clostridium phytofermentans*, *XYL3* from *Scheffersomyces stipitis*, and *TAL1* from *S*. *cerevisiae* but cannot utilize xylose, and strain Y184, which additionally lacks *ISU1* and *GRE3* and can thus respire xylose aerobically but not anaerobically \[[@pone.0212389.ref049]\]. Both Y22-3 and Y184 can grow in the toxic 9% ACSH, whereas strain Y128, which can ferment xylose anaerobically, cannot ([Fig 1](#pone.0212389.g001){ref-type="fig"}). To test the impact of mutations that enable anaerobic xylose utilization, we generated Y184 derivatives lacking *IRA2*, *BCY1*, or *HOG1* individually as well as *IRA2 HOG1* or *IRA2 BCY1* in combination, to define how each mutation impacts stress tolerance, growth, and metabolism. We also included Y184 Bcy1-AiD, in which an auxin-inducible degradation sequence is fused to the C-terminal of Bcy1 (in the presence of functional *IRA2* and *HOG1*); it is important to note this sequence alone does not enable degradation of Bcy1 but imparts rapid xylose fermentation in lab medium without the need for *HOG1* deletion \[[@pone.0212389.ref049]\].

![Stress susceptibility of strains engineered for xylose consumption.\
**A)** Strains were grown anaerobically in 9% ACSH, YPDX 9%/4.5%, YPDX 6%/3%, and YPDX 6%/3% + lignotoxins (LT) in 96-well plates, and final cell density at 48h was measured with a TECAN instrument. **B)** Same as A) except cells were grown in batch culture and OD was measured at 32 hours. Average and standard deviations of final ODs were calculated from three biological replicates. Asterisks denote significant differences compared to Y184 grown in each respective condition (paired T-Test, *p* \< 0.05).](pone.0212389.g001){#pone.0212389.g001}

Improving stress tolerance does not restore xylose fermentation in toxic hydrolysate {#sec008}
------------------------------------------------------------------------------------

We first measured tolerance of each strain to ACSH hydrolysates and rich laboratory medium containing mixed glucose/xylose with and without lignotoxins (LT), anaerobically in a 96-well plate reader. 9% ACSH is clearly inhibitory to growth, since all strains grew to much lower cell densities than in rich medium with lignotoxins added ([Fig 1](#pone.0212389.g001){ref-type="fig"}). Parental strains Y22-3 and Y184 showed the best growth in 9% ACSH, as indicated by final cell density, even though they cannot use the xylose after glucose is consumed. Y184 *ira2Δ* and Y184 *bcy1Δ* showed reduced growth compared to Y184, but still grew; Y128, Y184 *hog1Δ*, Y184 *ira2Δhog1Δ*, and Y184 *ira2Δbcy1Δ* were not able to grow. Thus, all strains lacking functional Hog1 showed increased sensitivity to 9% ACSH, as did the Y184 *ira2Δbcy1Δ* strain. Since Hog1 functions in the osmotic stress response, we reasoned the high sugar content of 9% ACSH may be responsible for the sensitivity of *hog1Δ* strains. However, the mutants were not sensitive to rich medium with sugar concentrations matching 9% ACSH (9% glucose, 4.5% xylose, [Fig 1A](#pone.0212389.g001){ref-type="fig"}). 9% ACSH is more concentrated than YPDX with 9% glucose / 4.5% xylose (1922 mmol / kg for 9% ACSH versus 1156 mmol / kg for YPDX). Yet, the mutants also showed increased sensitivity to 6% ACSH ([Fig 1B](#pone.0212389.g001){ref-type="fig"}), whose osmolality is on par with sugar-supplemented rich medium (1225 mmol / kg). Together, this suggests that it is not only the osmolality of 9% ACSH that is inhibitory to these strains. Strikingly, Y184 cells with the Bcy1-AiD tag, which enables anaerobic xylose fermentation, displayed maximal growth in 9% ACSH, comparable to Y184. Therefore, as we predicted, Y184 Bcy1-AiD lacks the extreme stress sensitivity seen in *hog1Δ* strains. While adding lignotoxins to YPDX medium decreased growth, it was not as inhibitory to any strain as 9% ACSH, suggesting either the lignotoxin cocktail \[[@pone.0212389.ref053]\] added was lower than toxin levels in real hydrolysate, that additional toxins not in our cocktail remain to be identified, or that it is the combination of osmolarity and toxins that contributes to toxicity.

We next studied glucose and xylose consumption in 9% ACSH to characterize fermentation rates. We expected the strains whose growth was sensitive to the stresses of ACSH would ferment worse compared to tolerant strains. Surprisingly, we found all strains, even those containing functional Hog1, were incapable of fermenting xylose in hydrolysate generated at high-glucan loading ([Fig 2C](#pone.0212389.g002){ref-type="fig"}, [S1C Fig](#pone.0212389.s001){ref-type="supplementary-material"}). Y128 and Y184 *hog1Δ* did not grow to densities as high as Y184, although Y184 *hog1Δ* was able to ferment the glucose and produce ethanol ([Fig 2D](#pone.0212389.g002){ref-type="fig"}). Y184 Bcy1-AiD showed division as robust as Y184 ([Fig 2A](#pone.0212389.g002){ref-type="fig"}), supporting observations seen with the 96-well plate screen. Consistent with our hypothesis, Y184 *hog1Δ* and especially Y128 cultures showed reduced glucose consumption over the time course, whereas stress-tolerant Y184 and Y184 Bcy1-AiD depleted the glucose by 40 hours ([Fig 2B](#pone.0212389.g002){ref-type="fig"}). Since we previously showed the Y184 Bcy1-AiD strain can ferment xylose anaerobically at higher rates than Y128 in laboratory medium \[[@pone.0212389.ref049]\] and has dramatically improved growth in 9% ACSH, we predicted Y184 Bcy1-AiD would display enhanced xylose consumption compared to Y128 and Y184 *hog1Δ* in 9% ACSH. Unexpectedly, this was not observed, as none of the strains used xylose in 9% ACSH ([Fig 2C](#pone.0212389.g002){ref-type="fig"}) even though two fermented the glucose. Several strains marginally used xylose in 6% ACSH ([S2C Fig](#pone.0212389.s002){ref-type="supplementary-material"}), but clearly ferment xylose in YPDX (see below), this suggests stresses in ACSH medium prevent xylose fermentation. Since the growth and glucose consumption of Y184 Bcy1-AiD is clearly recovered, these results suggest cellular stress is unlikely to be the cause of arrested xylose fermentation (see [Discussion](#sec011){ref-type="sec"}).

![9% ACSH is inhibitory to xylose fermentation.\
Batch cultures of Y128, Y184, Y184 *hog1Δ*, and Y184 Bcy1-AiD were grown anaerobically for 92 hours in 9% ACSH. **A.** Average OD~600~ measurements, **B.** glucose concentration, **C.** xylose concentration, and **D.** ethanol concentration over time, from three biological replicates.](pone.0212389.g002){#pone.0212389.g002}

Differential contributions of regulators to glucose versus xylose fermentation rates {#sec009}
------------------------------------------------------------------------------------

We next wanted to dissect the contribution of Ira2, Bcy1, and Hog1 to sugar fermentation. We worked with laboratory media supplemented with 60 g/L glucose and 30 g/L xylose to characterize fermentation when the strains are most productive, since they did not ferment xylose efficiently in ACSH. Interestingly, strains lacking Ira2 or Bcy1 or harboring the Bcy1-AiD fusion protein showed faster growth compared to the parental strains: all strains with these mutations reached maximum cell density by 24h, whereas Y22-3, Y184, and Y184 *hog1Δ* took 48h to reach maximal titers ([Fig 3A](#pone.0212389.g003){ref-type="fig"}, [S3A Fig](#pone.0212389.s003){ref-type="supplementary-material"}). Although it was not statistically significant in this growth assay, we noticed in the 96-well plate assay ([Fig 1](#pone.0212389.g001){ref-type="fig"}) strains lacking *IRA2* or *BCY1* consistently grew to lower cell densities than the parental strains. Deletion of *HOG1* from Y184 reduced growth rate and glucose consumption rate compared to the other strains, whereas combined deletions of *HOG1* and *IRA2* produced a strain with fast growth rates and the ability to grow to a higher cell density than Y22-3 and Y184 ([Fig 3A and 3B](#pone.0212389.g003){ref-type="fig"} and [S3A and S3B Fig](#pone.0212389.s003){ref-type="supplementary-material"}). Thus, the beneficial effect of *IRA2* deletion overrides the deleterious effect of *HOG1* deletion for glucose-based growth.

![PKA activity increases growth, while *hog1Δ* improves xylose consumption.\
Batch cultures were grown in YPDX 6%/3% for 96 hours. Measurements are averages from three biological replicates. **A.** The average dry-cell weight biomass (g per L culture) measured at 6, 24, and 48 h post inoculation. Asterisk indicates a significant difference (p\< 0.055) between the 24h and 48h time point within each strain. For all strains except Y184 and Y184 *hog1Δ*, the biomass accumulated was not significantly different at 48h compared to 24h, indicating faster saturation of those cultures. **B.** Specific glucose consumption rates calculated from the exponential phase of growth. **C.** Specific xylose consumption rate calculated from the stationary phase of growth. **D.** Ethanol titer at 48 hours post inoculation. For **B,C,D**, asterisks denote significant differences compared to Y184 (paired T-Test, *p* \< 0.05).](pone.0212389.g003){#pone.0212389.g003}

While mutations in PKA regulators increase growth on and consumption of glucose, the opposite was observed for xylose consumption. Strains lacking *HOG1* had the highest rates of xylose consumption compared to the parental strains, whereas strains with PKA mutations alone did not have a significantly different xylose consumption rate from the Y184 parental strain ([Fig 3C](#pone.0212389.g003){ref-type="fig"}). Thus, mutating *HOG1* is specifically important for efficient xylose fermentation. Moreover, Y128, Y184 *hog1Δ*, and Y184 *ira2Δhog1Δ* begin to ferment the xylose before glucose is completely depleted from the culture ([S3B and S3C Fig](#pone.0212389.s003){ref-type="supplementary-material"}). Correspondingly, Y128, Y184 *hog1Δ*, and Y184 *ira2Δhog1Δ* had the highest ethanol titer at 48 hours ([Fig 3D](#pone.0212389.g003){ref-type="fig"}, [S3D Fig](#pone.0212389.s003){ref-type="supplementary-material"}). Y184 Bcy1-AiD was previously shown to use xylose at a comparable rate to Y128 in YPX medium when cultured at a high cell density \[[@pone.0212389.ref049]\]. Interestingly, we discovered that the strain does not use xylose efficiently when the culture is started at low cell density ([Fig 3C](#pone.0212389.g003){ref-type="fig"}), even though we recapitulate robust xylose utilization at high cell density in YPDX ([S4A Fig](#pone.0212389.s004){ref-type="supplementary-material"}). The reason for this unique phenotype is not known; importantly, it did not explain the lack of xylose consumption in ACSH, since inoculating cultures at high cell titers did not improve xylose fermentation in the strain ([S4B Fig](#pone.0212389.s004){ref-type="supplementary-material"}).

Hog1 kinase activity decreases xylose fermentation {#sec010}
--------------------------------------------------

*HOG1* deletion allows for efficient xylose fermentation in YPDX. To test if it is the kinase activity of Hog1, as opposed to other effects of the Hog1 protein, we tested if the catalytically inactive *hog1-D144A* allele or truncated *HOG1* recapitulating Y128's mutation (*hog1 A844Δ*) could block xylose fermentation when introduced into Y184 *ira2Δhog1Δ*, equal to reintroducing the functional *HOG1* allele. We saw the catalytic activity of Hog1 was required to suppress anaerobic xylose fermentation: reintroducing wildtype *HOG1* increased glucose consumption and inhibited xylose fermentation, whereas expression of catalytically inactive or truncated Hog1 did not significantly affect the glucose or xylose consumption rate, since the strains matched the performance of Y184 *ira2Δhog1Δ* ([Fig 4](#pone.0212389.g004){ref-type="fig"}). This reveals Hog1 kinase activity normally inhibits xylose fermentation, suggesting Hog1 actively phosphorylates one or more targets to prevent xylose utilization.

![Hog1 activity blocks xylose consumption.\
Wildtype, catalytically inactive (*hog1*^*D144A*^), and truncated (*hog1*^*A844𝞓*^) *HOG1* alleles were expressed in Y184 *ira2Δhog1Δ* cells and grown in batch culture for 96 hours in YPDX 6%/3%. Rate measurements were based on average and standard deviation from three biological replicates. **A.** Average growth rate calculated from the exponential phase of growth. **B.** Specific glucose consumption rate calculated from the exponential phase of growth. **C.** Specific xylose consumption rate calculated from the stationary phase of growth. Asterisks denote significant differences from Y184 *ira2Δhog1Δ*/*HOG1* (paired T-Test, *p* \< 0.05).](pone.0212389.g004){#pone.0212389.g004}

We performed phosphoproteomic analysis to implicate potential Hog1 targets impacting xylose consumption. Y184 *ira2Δ* and Y184 *ira2Δhog1Δ* were grown anaerobically in batch culture in YPX medium, and phospho-proteomes were measured by quantitative mass-spectrometry (see [Methods](#sec002){ref-type="sec"}). We identified only 11 phosphopeptides whose abundance was reproducibly lower in Y184 *ira2Δhog1Δ* ([Table 2](#pone.0212389.t002){ref-type="table"}, see [methods](#sec002){ref-type="sec"}). Of these 11, four are linked to metabolism: E1 alpha subunit of pyruvate dehydrogenase (Pda1), pyruvate kinase (Cdc19), glyceraldehyde-3-phosphate dehydrogenase (Tdh1), and trehalose-6-phosphatase complex (Tsl1). Pda1, Cdc19, and Tdh1 have roles in glycolysis, whereas Tsl1 generates the overflow metabolite trehalose. In contrast, eight phosphopeptides showed reproducibly increased abundance in Y184 *ira2Δhog1Δ*. Of these eight, four are from proteins with unknown functions, one is a heat shock protein (Hsp26), two are components of the 40S ribosome (Rps6A, Rps6B), and one is an epsin-like protein involved in endocytosis ([Table 2](#pone.0212389.t002){ref-type="table"}). Several of these enzymes, including Cdc19 and Tsl1, directly interact with Hog1, and others harbor the known Hog1 consensus sites around the affected residue, suggesting Hog1 directly phosphorylates these proteins (see [Discussion](#sec011){ref-type="sec"}).

10.1371/journal.pone.0212389.t002

###### Significant phosphorylation changes in Y184 *ira2Δhog1Δ*.

![](pone.0212389.t002){#pone.0212389.t002g}

  Protein   Function                                     Phospho-site   Average Log2(fold change) in Y184 *ira2Δhog1Δ versus Y184 ira2Δ*
  --------- -------------------------------------------- -------------- ------------------------------------------------------------------
  PDA1      Pyruvate dehydrogenase                       Y344           -1.66
  EIS1      Eisosome protein                             T767           -1.44
  PDA1      Pyruvate dehydrogenase                       S336           -1.16
  EIS1      Eisosome protein                             S763           -1.14
  TSL1      Trehalose 6-phosphate synthase/phosphatase   S266           -1.10
  HBT1      Shmoo tip protein                            S41            -1.08
  MRP51     Mitochondrial small ribosomal protein        S327           -1.03
  CDC19     Pyruvate kinase                              S22            -0.93
  TDH1      Glyceraldehyde-3-phosphate dehydrogenase     T136           -0.84
  RPS21B    40S ribosomal subunit                        S65            -0.74
  HBT1      Shmoo tip protein                            S363           -0.74
  ENT1      Epsin-like protein                           S317           0.68
  INA1      Unknown function                             S652;S657      0.76
  YNL115C   Unknown function                             S244           0.79
  INA1      Unknown function                             S654;S657      0.86
  YNL115C   Unknown function                             S42            1.00
  HSP26     Small heat shock protein                     S208           1.02
  RPS6B     40S ribosomal subunit                        S232           1.14
  RPS6A     40S ribosomal subunit                        S232           1.14

Discussion {#sec011}
==========

Our results provide new insights into how mutation of different signaling proteins can impart distinct physiological responses that, when integrated, improve anaerobic conversion of sugars to products, in this case ethanol. We show mutations in RAS/PKA signaling that up-regulate PKA activity enhance growth and perhaps glucose consumption rates, but possibly at a cost of final cell density, whereas deletion of HOG1 is essential for xylose fermentation but at the expense of hydrolysate tolerance. Together, these results suggest several important results relevant to lignocellulosic fermentation.

PKA and Hog1 contribute separable features to xylose fermentation. Increased PKA activity is known to increase cell growth rate and glucose consumption \[[@pone.0212389.ref058]\]. PKA upregulates expression of ribosome biogenesis genes, which supports rapid growth \[[@pone.0212389.ref059],[@pone.0212389.ref060]\]. Moreover, it promotes glycolytic flux by inducing transcription of genes and phosphorylating enzymes involved in glycolysis \[[@pone.0212389.ref061]--[@pone.0212389.ref063]\]. We recently showed PKA also has roles in the hypoxic response when cells are grown anaerobically on xylose \[[@pone.0212389.ref049]\]. This response is mediated by the Azf1 and Mga2 transcription factors and may further promote glycolytic flux. Therefore, it is consistent that we find strains with deletions of RAS/PKA regulators display faster growth ([Fig 3A](#pone.0212389.g003){ref-type="fig"}, [S3A Fig](#pone.0212389.s003){ref-type="supplementary-material"}). Despite the increased growth and glucose consumption rates when PKA regulators are deleted, this effect is not as dramatic with xylose. While strains with mutations in *IRA2* or *BCY1* do consume more xylose than Y184 ([S3C Fig](#pone.0212389.s003){ref-type="supplementary-material"}), the rates of consumption are not significantly faster than Y184 ([Fig 3C](#pone.0212389.g003){ref-type="fig"}). The reduced final-cell titers seen in strains with up-regulated RAS/PKA may result from an inability to accumulate storage carbohydrates. During the diauxic shift, glycogen storage occurs when glucose has been depleted to fifty percent of its starting concentration \[[@pone.0212389.ref064]\]. However, increased PKA activity prevents accumulation of storage carbohydrates, such as glycogen and trehalose, by inhibiting expression of biosynthesis enzymes and activating catabolic enzymes \[[@pone.0212389.ref065]--[@pone.0212389.ref069]\]. In our strains lacking RAS/PKA inhibitors, it is possible upon glucose depletion, the cells lack stored carbohydrates to metabolize, limiting cell titers compared to strains with functional *IRA2* and *BCY1* ([Fig 1](#pone.0212389.g001){ref-type="fig"}, [S3A Fig](#pone.0212389.s003){ref-type="supplementary-material"}).

In contrast to PKA upregulation, *HOG1* deletion specifically affects xylose utilization. Our results show that under standard conditions, even in the absence of added stress, Hog1 kinase activity inhibits xylose utilization, perhaps by directly phosphorylating glycolytic enzymes ([Fig 4C](#pone.0212389.g004){ref-type="fig"}, [Table 2](#pone.0212389.t002){ref-type="table"}). Although typically thought of as a stress regulator, Hog1 has recently been implicated in the response to glucose \[[@pone.0212389.ref028],[@pone.0212389.ref029],[@pone.0212389.ref070]\] and was shown to phosphorylate the glycolytic enzyme Pfk26 \[[@pone.0212389.ref071]\] and physically interact with Cdc19, Pfk1, and Pfk2 \[[@pone.0212389.ref072]\]. Hog1 also plays an important role in glycerol production, which may influence glycolytic flux to steer production from pyruvate towards glycerol \[[@pone.0212389.ref073]--[@pone.0212389.ref078]\]\]. The enzymes we detected with significant phosphorylation differences upon *HOG1* deletion function lower in glycolysis, after the entry point of xylose via the pentose phosphate pathway ([Table 2](#pone.0212389.t002){ref-type="table"}), but we cannot exclude that other enzymes or regulators are also affected. Modeling of glycolytic flux during osmoadaption suggests Hog1 activity stabilizes pyruvate production to prevent starvation \[[@pone.0212389.ref076]\], which may account for the decreased phosphorylation of Cdc19's activation site in *hog1Δ* mutants ([Table 2](#pone.0212389.t002){ref-type="table"}).

An interesting question is the relationship between PKA and Hog1 activity. We previously found Y184 *bcy1Δ* cells display reduced phosphorylation of the Hog1 protein on its activating site when grown anaerobically in YPX medium \[[@pone.0212389.ref049]\], suggesting a PKA-dependent mechanism of inhibiting Hog1 activity to allow xylose fermentation. Hog1 was shown to be activated during glucose depletion \[[@pone.0212389.ref028],[@pone.0212389.ref070]\]. It is possible as cells begin to deplete glucose from YPDX, Hog1 becomes activated in Y184 but that this is suppressed when PKA is up-regulated via *BCY1* or *IRA2* deletion. The largest effects on xylose metabolism occur when PKA upregulation and *HOG1* deletion are combined. Unfortunately, a byproduct of this is likely causing extreme stress sensitivity. Strains lacking *HOG1* (Y128, Y184 *hog1Δ*, and Y184 *ira2Δhog1Δ*) are especially sensitive to hydrolysate (Figs [1](#pone.0212389.g001){ref-type="fig"} and [2A](#pone.0212389.g002){ref-type="fig"}, [S1A Fig](#pone.0212389.s001){ref-type="supplementary-material"}). Moreover, the combination of upregulated PKA and *HOG1* deletion may exacerbate stress sensitivity, since PKA suppresses the stress response \[[@pone.0212389.ref024]\], while Hog1 activates it \[[@pone.0212389.ref025]\]. These strains are able to ferment xylose in favorable conditions ([Fig 3C](#pone.0212389.g003){ref-type="fig"}, [S3C Fig](#pone.0212389.s003){ref-type="supplementary-material"}), but are unable to ferment the sugar in toxic 9% ACSH ([Fig 2C](#pone.0212389.g002){ref-type="fig"}, [S1C Fig](#pone.0212389.s001){ref-type="supplementary-material"}).

We hypothesized improving stress tolerance would improve xylose fermentation in stressful conditions. We predicted Y184 Bcy1-AiD, which harbors functional *HOG1* but can ferment xylose anaerobically in rich medium when started at high titers \[[@pone.0212389.ref049]\], would display both higher stress tolerance and anaerobic xylose fermentation in hydrolysate. Interestingly, while Y184 Bcy1-AiD clearly grew well in 9% ACSH, it did not utilize the xylose even when started at high cell titer (Figs [1](#pone.0212389.g001){ref-type="fig"}, [2A and 2C](#pone.0212389.g002){ref-type="fig"}, [S4B Fig](#pone.0212389.s004){ref-type="supplementary-material"}). This suggests stress sensitivity is not the sole factor limiting xylose fermentation. There are many types of lignotoxins present in hydrolysates \[[@pone.0212389.ref052]\], and while their effects are somewhat understood, many of their specific targets remain to be elucidated \[[@pone.0212389.ref033]\]. One possibility is that toxins are directly inhibiting enzymes required for anaerobic xylose fermentation, as shown in *Escherichia coli* where feruloyl and coumaroyl amides were discovered to be allosteric inhibitors of *de novo* nucleotide biosynthetic enzymes \[[@pone.0212389.ref079]\]. Jayakody et al. (2018) found that glycoaldehyde and methyglyoxal present in hydrolysate are key inhibitors of xylose fermentation \[[@pone.0212389.ref080]\]. Furthermore, acetic acid is known to decrease enolase activity, ultimately slowing down glycolysis \[[@pone.0212389.ref081]\]. This has led to other groups engineering yeast to reduce and ferment acetate or increase acetate tolerance \[[@pone.0212389.ref043],[@pone.0212389.ref082],[@pone.0212389.ref083]\]. More studies identifying the targets of lignotoxins will help to clarify the bottleneck in xylose metabolism when microorganisms are grown in hydrolysate media.

Our results also revealed unexpected information on the different routes of PKA regulation with regard to the stress response. Removing either *IRA2* or *BCY1* had mild impacts on ACSH tolerance, but deletion of both genes greatly impacted tolerance of 9% ACSH (Figs [1](#pone.0212389.g001){ref-type="fig"} and [2A](#pone.0212389.g002){ref-type="fig"}, [S1A Fig](#pone.0212389.s001){ref-type="supplementary-material"}). This suggests there are multiple lines of partially redundant regulation of stress tolerance by the RAS/PKA pathways. Upregulation RAS by *IRA2* deletion is predicted to increase cAMP and thus PKA activity \[[@pone.0212389.ref084]\], whereas deletion of *BCY1* removes the cAMP-responsive inhibitor of PKA. One possibility is PKA is only partially upregulated by single-gene deletion, but double-deletion of *IRA2* and *BCY1* produces much stronger activation and thus complete suppression of the stress response. There are other methods of RAS/PKA pathway regulation which support the possibility that single deletion of *IRA2* or *BCY1* causes only a partial upregulation. The RAS/PKA pathway undergoes feedback inhibition to control cAMP concentrations through predicted PKA-directed phosphorylation of Cdc25 and Pde1 \[[@pone.0212389.ref085]\]. Furthermore, the interaction between the catalytic and regulatory subunits of PKA is regulated by other factors, including kelch-repeat proteins Krh1/2 \[[@pone.0212389.ref086]\]. Another possibility is PKA may be directed to different substrates in different situations. Beyond allosteric cAMP regulation influenced by RAS, Bcy1 is also regulated by phosphorylation, which can influence PKA substrate specificity and localization \[[@pone.0212389.ref087]--[@pone.0212389.ref091]\]. Recent studies in mammalian cells show the negative regulator of PKA does not dissociate from the active kinase at physiological cAMP levels \[[@pone.0212389.ref092]\], and the substrate determines the dissociation rate of catalytic and regulatory subunits \[[@pone.0212389.ref093]\]. Thus, activation of PKA via Bcy1-cAMP binding may provide different effects than if Bcy1 is missing from the cell. Finally, it is also possible that PKA-independent effects of *IRA2* deletion separately regulate the stress response. Future studies to dissect these and other effects will contribute to our understanding of how to engineer cells for anaerobic xylose fermentation in lignocellulosic hydrolysates.

Supporting information {#sec012}
======================

###### 9% Growth and metabolism profiles in 9% ACSH.

Batch cultures were grown in 9% ACSH anaerobically for 92 hours. Data represent average and standard deviation from three biological replicates. **A.** OD~600~ measurements over time. Glucose (**B.**) and xylose (**C.**) concentration in the media over time.

(TIF)

###### 

Click here for additional data file.

###### Growth and metabolism profiles in 6% ACSH.

As described in [S1 Fig](#pone.0212389.s001){ref-type="supplementary-material"} except for anaerobic 6% ACSH growth, measuring dry-cell weight (**A.**), and glucose (**B.**), xylose (**C.**), and ethanol (**D.**) media concentration over time.

(TIF)

###### 

Click here for additional data file.

###### Growth and metabolism profiles in YPDX 6%/3%.

As described in [S1 Fig](#pone.0212389.s001){ref-type="supplementary-material"} except for anaerobic YPDX 6%/3% growth, measuring dry-cell weight (**A.**), and glucose (**B.**), xylose (**C.**), and ethanol (**D.**) media concentration over time.

(TIF)

###### 

Click here for additional data file.

###### High starting cell titers increases xylose consumption in nutrient-rich medium, but not ACSH.

Batch cultures were grown anaerobically for 96 hours in YPDX 6%/3% (**A.**) or 6% ACSH (**B.**). Cultures were started at an OD~600~ of 3. Data represent average and standard deviation of three biological replicates. Comparing Panel A to [Fig 3C](#pone.0212389.g003){ref-type="fig"} shows that the Y184 Bcy1-AiD strain ferments xylose when the culture is inoculated at a higher starting OD but not when inoculated at a lower cell density.

(TIF)

###### 

Click here for additional data file.

###### Concentrations of lignotoxins present in 9% ACSH and YPDX 6%/3% + LT.

This table lists the concentrations of lignotoxins identified in 9% ACSH and the corresponding concentrations added to generate YPDX 6%/3% +LT.

(XLSX)

###### 

Click here for additional data file.
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